It is a pharma public limited company based in Indore, Madhya Pradesh, India, established in 2022.
2022 | Indore, Madhya Pradesh, India | ActiveGynofem Healthcare And Pharmaceuticals Limited, a active public limited company, was established on 13 October 2022 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24290MP2022PLC063077. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.92 Cr.
Employing 52 professional, Its leadership includes Nishi Kant Joshi (Director), Kartikay Joshi (Director), Anurag Mendhe (Director). It holds ₹6.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 75/2/16, S K Compound, Lasudiya Mori Dewas Naka, Indore, Madhya Pradesh, 452010.
U24290MP2022PLC063077
063077
13 October 2022
₹10.00 Cr
₹9.92 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Gynofem Healthcare And Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nishi Kant Joshi | Director | 13 Oct 2022 | Current |
| Kartikay Joshi | Director | 13 Oct 2022 | Current |
| Anurag Mendhe | Director | 13 Oct 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gynofem Healthcare And Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Gynofem Healthcare And Pharmaceuticals had a promoter holding of 79.84% and a public holding of 20.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Feb 2024 | Axis Bank Limited | ₹6.50 M | Open |
Explore comprehensive loan charge details -
Gynofem Healthcare And Pharmaceuticals has a workforce of 52 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gynofem Healthcare And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gynofem Healthcare And Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gynofem Healthcare And Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Gynofem Healthcare And Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 0.65 Cr with Charge ID 100876856 was registered on 02 Feb 2024. was recorded as a recent event.
Progress on Nishi Kant Joshi was appointed as a Director was appointed as a Director on 13 Oct 2022 & has been associated with this company since 3 years 1 month . was documented.
Progress on Kartikay Joshi was appointed as a Director was appointed as a Director on 13 Oct 2022 & has been associated with this company since 3 years 1 month . was documented.
The activity Anurag Mendhe was appointed as a Director was appointed as a Director on 13 Oct 2022 & has been associated with this company since 3 years 1 month . was completed.
The CIN of Gynofem Healthcare And Pharmaceuticals Limited is U24290MP2022PLC063077.
Gynofem Healthcare And Pharmaceuticals Limited is headquartered at 75/2/16, S K Compound, Lasudiya Mori Dewas Naka, Indore, Madhya Pradesh, 452010.
Gynofem Healthcare And Pharmaceuticals Limited was incorporated on 13 October 2022.
The current directors of Gynofem Healthcare And Pharmaceuticals Limited are
The primary industry of Gynofem Healthcare And Pharmaceuticals Limited is Trade.
Gynofem Healthcare And Pharmaceuticals Limited is unlisted.
The authorized capital of Gynofem Healthcare And Pharmaceuticals Limited is ₹10.00 Cr, and the paid-up capital is ₹9.92 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX